This page is provided for research and educational purposes only and does not provide medical advice, diagnosis, treatment recommendations, dosing instructions, or instructions for human use. Research findings should be interpreted within the population, model, formulation, route, outcomes, and study design reported by each cited source.
BPC-157 (10 mg Vial)
BPC-157 is a synthetic 15-amino-acid peptide examined in laboratory and animal research[1][5]. This article distinguishes those experimental findings from human clinical evidence and summarizes the limitations of the cited studies.
Quick Reference
What is BPC-157?
BPC-157 is a synthetic peptide containing 15 amino acids. Laboratory research has examined its effects on rat tendon tissue and tendon fibroblasts, including cell migration and survival during oxidative stress[5]. These findings do not establish clinical benefits or human safety.
Storage Instructions
Proper storage preserves peptide quality.
• Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; minimize moisture exposure.
• Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); prepare aliquots if needed and avoid freeze–thaw.
• Allow vials to reach room temperature before opening to reduce condensation uptake.
How is BPC-157 studied?
BPC-157 has been studied in rat models of colocutaneous fistula healing, including experiments on nitric-oxide signalling[1]. Separate work using rat tendon explants and tendon fibroblasts examined tissue outgrowth, cell migration and stress survival[5]. These experimental models do not establish efficacy in human injuries. A Phase 1 PCO-02 study is registered, but the registry has no posted results[6]; its listing alone cannot substantiate claims of good tolerability or an absence of serious adverse events.
What does the research report about BPC-157?
• A rat fistula study reported healing outcomes in colon and skin defects[1].
• Tendon-explant and fibroblast experiments reported outgrowth, migration and survival under oxidative stress[5].
• The registered Phase 1 PCO-02 study has no posted results[6].
• These sources do not establish long-term human safety, effective treatment or a recommended administration method.
Important Note
This content is provided for scientific research and educational purposes only. It does not provide medical advice, diagnosis, treatment, dosing, or administration instructions. The compounds discussed may be investigational and are not presented as approved for human use.
What are the limitations of the research on BPC-157?
Evidence should be interpreted within the population, experimental model, formulation, route, outcome measures, and study design used in each cited source. Preclinical or early-stage findings do not establish clinical efficacy, safety, or approved human use. Where human evidence is available, results should not be generalized beyond the populations and conditions actually studied.
